Tell your friends why this matters

Dear Friend,

At the beginning of the month, Foundation CEO Todd Sherer, PhD, shared a few of the latest scientific developments that are bringing us closer to a cure. This Parkinson's Awareness Month, we'd like your help to spread the word of the importance of this mission. Here's how you can help:

1. Give to support critical research
2. Share this badge with your social networks
3. Rally family and friends to do the same

This month, 1,500 members of our community have already shown their support for MJFF and vital research. Help us reach 2,500 before April is over. 

As always, thanks for your continued support,

Emily Moyer

Senior Vice President, Marketing and Digital Strategies

Dear Friend,

Today marks the kickoff of Parkinson's Awareness Month. As such, many of you in our passionate community will take this opportunity to voice your urgency for a cure.

For us at The Michael J. Fox Foundation (MJFF), this month -- and each one after -- marks another step toward better treatments and a cure for Parkinson's disease (PD). Your support is key to this progress, including these recent advances in the field:

• Earlier this month, the Foundation launched the S4 study  to measure the toxic protein alpha-synuclein outside the brain. By analyzing levels in saliva, spinal fluid, blood and more, researchers aim to form a holistic picture of how this protein relates to Parkinson's disease.
• Researchers celebrated record pace of recruitment for Phase III testing of isradipine, a hypertension medication that may slow Parkinson's progression. We don't yet know if the drug will benefit people with PD, but the recruitment strategy can serve as a model for other trials.
• On Tuesday, an advisory panel to the Food and Drug Administration (FDA) voted in favor of approving Nuplazid, a new drug to treat Parkinson's psychosis (hallucinations and delusions). The FDA will make its final decision by May 1, 2016.

I say this often: This community has the power to change the prognosis of Parkinson's.  Our goals are ambitious, but through your support, we can transform scientific advances into life-changing therapies for Parkinson's patients and families. As always, we honor your trust with a commitment to efficiency: 89 cents of every dollar spent goes directly to research programs.

I hope this Parkinson's Awareness Month you feel as we do -- that a cure for Parkinson's is within reach.

 

All the best,

 

Todd Sherer, PhD

CEO